ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1,3,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
2,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
5,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
6,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
7,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
7,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
8,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
11,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
11,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
12,3,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
12,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
13,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
13,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
14,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
15,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
15,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
15,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
15,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
16,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
16,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
17,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
17,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
17,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
17,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
18,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
18,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
19,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
19,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
19,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
20,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
20,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
20,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
21,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
22,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
22,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
23,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
24,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
24,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
25,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
25,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
25,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
25,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
26,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
26,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
26,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
27,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
27,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
28,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
29,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
29,2,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
29,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
29,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
29,5,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
30,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
31,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
31,2,Flavobacterium infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
31,3,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
31,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
31,5,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
32,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
32,2,Flavobacterium infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
32,3,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
32,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
32,5,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
33,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
33,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
33,3,Flavobacterium infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
33,4,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
33,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
33,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
33,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
33,8,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
33,9,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
34,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
34,2,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
34,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
34,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
34,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
34,6,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
34,7,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
34,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
35,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
35,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
36,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
36,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
37,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
38,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
38,2,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
39,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
39,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
40,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
40,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
40,3,Flavobacterium infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
40,4,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
40,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
40,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
40,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
40,8,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
40,9,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
41,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
42,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
42,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
42,3,Flavobacterium infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
42,4,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
42,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
42,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
42,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
42,8,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
42,9,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
43,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
43,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
43,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
44,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
44,2,Central nervous system infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
44,3,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
44,4,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
45,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
45,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
46,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
47,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
47,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
48,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
49,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
50,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
